In vitro activities of antibiotics against Plasmodium falciparum are inhibited by iron

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 6, 2001, Pages 1746-1750

  Pradines, Bruno ^a   Rogier, Christophe ^a   Fusai, Thierry ^a   Mosnier, Joel ^a   Daries, William ^a   Barret, Eric ^a   Parzy, Daniel ^a  

^a SERVICE DE SANTÉ DES ARMÉES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFACLOR; CEFALEXIN; CEFAMANDOLE; CEFOTAXIME; CEFOXITIN; CEFTRIAXONE; DOXYCYCLINE; ERYTHROMYCIN; FOSFOMYCIN; LINCOMYCIN; METRONIDAZOLE; MINOCYCLINE; NORFLOXACIN; OFLOXACIN; OXYTETRACYCLINE; RIFAMPICIN; ROLITETRACYCLINE; ROXITHROMYCIN; SPIRAMYCIN; TETRACYCLINE; THIAMPHENICOL; TOBRAMYCIN;

ANTIBIOTIC THERAPY; ANTIMALARIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CATALYSIS; CHEMOPROPHYLAXIS; DNA SYNTHESIS; DRUG EFFICACY; ENERGY METABOLISM; IN VITRO STUDY; IRON CHELATION; IRON METABOLISM; MOLECULAR CLONING; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMALARIALS; CELLS, CULTURED; CHLOROQUINE; DRUG RESISTANCE, MULTIPLE; FERRIC COMPOUNDS; MICROBIAL SENSITIVITY TESTS; PLASMODIUM FALCIPARUM;

EID: 0035008795     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.6.1746-1750.2001     Document Type: Article

References (58)

1. Andersen, S. L., A. Ager, P. McGreevy, B. G. Schuster, D. Wesche, R. Kuschner, C. Ohrt, W. Ellis, R. Rossan, and J. Berman. 1995. Activity of azithromycin as a blood schizonticide against rodent and human plasmodia in vivo. Am. J. Trop. Med. Hyg. 52:154-161.
2. Atkinson, C. T., M. T. Bayne, V. R. Gordeuk, G. M. Brittenham, and M. Aikawa. 1991. Specific ultrastructural effects of desferrioxamine on Plasmodium falciparum in vitro. Am. J. Trop. Med. Hyg. 45:593-601.
3. Basco, L. K., and J. Le Bras. 1993. Activity in vitro of doxycycline against multidrug-resistant Plasmodium falciparum. Trans. R. Soc. Trop. Med Hyg. 87:469-470.
4. Baudon, D., G. Martet, B. Pascal, J. Bernard, A. Keundjian, and R. Laroche. 1999. Efficacy of daily antimalarial chemoprophylaxis in tropical Africa using either doxycycline or chloroquine-proguanil: study conducted in 1996 in the French Army. Trans. R. Soc. Trop. Med. Hyg. 93:1-2.
5. de Paula, F. C. S., S. Carvalho, H. A. Duarte, E. B. Paniago, A. S. Mangrich, and E. C. Pereira-Maia. A physicochemical study of the tetracycline coordination to oxovanadium (IV). J. Inorg. Biochem. 76:221-230.
6. Divo, A. A., T. G. Geary, and J. B. Jensen. 1985. Oxygen- and time-dependent effects of antibiotics and selected mitochondrial inhibitors on Plasmodium falciparum in culture. Antimicrob. Agents Chemother. 27:21-27.
7. Dunn, C. J., and L. B. Barradell. 1996. Azithromycin: a review of its pharmacological properties and use as a 3 day therapy in respiratory tract infections. Drugs 51:483-505.
8. Franklin, T. J. 1963. The inhibition of incorporation of leucine into proteins of cell-free systems from rat liver and Escherichia coli by chlorotetracycline. Biochem. J. 87:449-453.
9. Freerksen, E., E. W. Kanthumkumva, and A. R. K. Kholowa. 1996. Cotrifazid - an agent against malaria. Chemotherapy 42:391-401.
10. Gardner, M. J., D. H. Williamson, and R. J. M. Wilson. 1991. A circular DNA in malaria parasites encodes an RNA polymerase like that of prokaryotes and chloroplasts. Mol. Biochem. Parasitol. 44:115-124.
11. Geary, T. G., and J. B. Jensen. 1983. Effects of antibiotics on Plasmodium falciparum in vitro. Am. J. Trop. Med. Hyg. 32:221-225.
12. Geary, T. G., A. A. Divo, and J. B. Jensen. 1988. Uptake of antibiotics by Plasmodium falciparum in culture. Am. J. Trop. Med. Hyg. 38:466-469.
13. Gingras, B. A., and J. B. Jensen. 1992. Activity of azithromycin (CP-62,993) and erythromycin against chloroquine sensitive and chloroquine resistant strains of Plasmodium falciparum in vitro. Am. J. Trop. Med. Hyg. 47:378-382.
14. Gingras, B. A., and J. B. Jensen. 1993. Antimalarial activity of azithromycin and erythromycin against Plasmodium berghei. Am. J. Trop. Med. Hyg. 49: 101-105.
15. Goerg, H., S. A. Ochola, and R. Goerg. 1999. Treatment of malaria tropica with a fixed combination ot rifampicin, co-trimoxazole and isoniazid: a clinical study. Chemother. 45:68-76.
16. Gras, C., R. Laroche, L. Guelain, G. Martet, M. Merlin, and J. E. Touze. 1993. Chimioprophylaxie du paludisme au Cambogge par la doxycycline. Presse Med. 22:491-492.
17. Gras, C., R. Laroche, L. Guelain, G. Martet, M. Merlin, G. Pottier, M. Guisset, and J. E. Touze. 1993. Place actuelle de la doxycycline dans la chimioprophylaxie du paludisme à Plasmodium falciparum. Bull. Soc. Pathol. Exot. 86:52-55.
18. Grenier, D., M. P. Huot, and D. Mayrand. 2000. Iron-chelating activity of tetracyclines and its impact on the susceptibility of Actinobacillus actinomycetemcomitans to these antibiotics. Antimicrob. Agents Chemother. 44:763-766.
19. Hamzah, J., T. Skinner-Adams, and T. M. E. Davis. 2000. In vitro antimalarial activity of trovafloxacin, a fourth-generation fluoroquinolone. Acta Trop. 74:39-42.
20. Hider, R. C., and Z. Liu. 1997. The treatment of malaria with iron chelators. J. Pharm. Pharmacol. 49:59-64.
21. Khan, B., A. D. Brandling-Bennett, W. M. Watkins, A. J. Oloo, P. Ojoo, and D. K. Koech. 1991. Plasmodium sensitivity to erythromycin and 4-amino-quinoline combination in vitro. Ann. Trop. Med. Parasitol. 2:215-222.
22. Kiatfuengfoo, R., T. Suthiphongchai, P. Prapunwattana, and V. Yuthavong. 1989. Mitochondria as the site of action of tetracycline on Plasmodium falciparum. Mol. Biochem. Parasitol. 34:109-116.
23. Krungkai, J. 1995. Purification, characterization and localization of mitochondrial dihydroorotate dehydrogenase in Plasmodium falciparum, human malaria parasite. Biochem. Biophys. Acta 1243:351-360.
24. Kuschner, R. A., D. G. Heppner, S. L. Andersen, B. T. Wellde, T. Hall, I. Schneider, W. R. Ballou, G. Foulds, J. C. Sadoff, B. Schuster, and D. N. Taylor. 1994. Azithromycin prophylaxis against a chloroquine resistant strain of Plasmodium falciparum. Lancet 343:1396-1397.
25. Lambros, C., and J. P. Vanderberg. 1979. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 65:418-420.
26. Looareesuwan, S., C. Vivaran, H. K. Webster, D. E. Kyle, D. B. Hutchinson, and C. J. Canfield. 1996. Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria falciparum malaria in Thailand. Am. J. Trop. Med. Hyg. 54:62-66.
27. Looareesuwan, S., C. Vivaran, S. Vanijanonta, P. Wilairanata, P. Charoenlarp, C. J. Canfield, and D. E. Kyle. 1994. Randomized trial of mefloquine-doxycycline, and artesunate-doxycycline for treatment of acute uncomplicated falciparum malaria. Am. J. Trop. Med. Hyg. 50:784-789.
28. Marussig, M., A. Motard, L. Renia, D. Baccam, J. Le Bras, G. Charmot, and D. Mazier. 1993. Activity of doxycycline against pre-erythrocytic malaria. J. Infect. Dis. 168:1603-1604.
29. Maxwell, A. 1992. The molecular basis of quinolone action. Antimicrob. Agents Chemother. 30:409-416.
30. McColm, A. A., and N. McHardy. 1984. Evaluation of a range of antimicrobial agents against the parasitic protozoa, Plasmodium falciparum, Babesia rhohaini and Theileria parva in vitro. Ann. Trop. Med. Parasitol. 78:345-354.
31. Meshnick, S. R., Y. Z. Yang, V. Lima, F. Kuypers, S. Kamchonwongpaisan, and Y. Yuthavong. 1993, Iron-dependent free radical generation from the antimalarial agent artemisinin (Qinghaosu). Antimicrob. Agents Chemother. 37:1108-1114.
32. Midgley, J. M., D. W. Keter, J. D. Phillipson, S. Grant, and D. C. Warhurst. 1988. Quinolines and multiresistant Plasmodium falciparum. Lancet ii:281.
33. Miles, A. A., and J. P. Maskell. 1985. The antagonism of tetracyclines and ferric iron in vivo. J. Med. Microbiol. 20:17-26.
34. Miles, A. A., and J. P. Maskell. 1986. The neutralization of antibiotic action by metallic cations and iron chelators. J. Antimicrob. Chemother. 17:481-487.
35. Na-Bangchang, K., T. Kanda, P. Tipawangso, A. Thanavibul, K. Suprakob, M. Ibrahim, Y. Wattanagoon, and J. Karbwang. 1996. Activity of artemether-azithromycin versus artemether-doxycycline in the treatment of multiple drug resistant falciparum malaria. Southest Asian J. Trop. Med. Public Health 27:522-525.
36. Olliaro, P., and D. Wirth. 1997. New targets for antimalarial drug discovery. J. Pharm. Pharmacol. 49:29-33.
37. Pang, L. W., E. F. Boudreau, G. E. Childs, H. K. Webster, C. Supanantalerk, and P. Somutsakorn. 1985. Failure of large-dose erythromycin in combination with a standard dose of chloroquine or quinine in the treatment of human falciparum malaria. Bull. World Health Org. 63:739-743.
38. Pradines, B., M. Mabika Mamfoumbi, D. Parzy, M. Owono Medang, C. Lebeau, J. R. Mourou Mbina, J. C. Doury, and M. Kombila. 1999. In vitro susceptibility of African isolates of Plasmodium falciparum from Gabon to pyronaridine. Am. J. Trop. Med. Hyg. 60:105-108.
39. Pradines, B., F. Ramiandrasoa, L. K. Basco, L. Bricard, G. Kunesch, and J. Le Bras. 1996. In vitro activities of novel catecholate siderophore against Plasmodium falciparum. Antimicrob. Agents Chemother. 40:2094-2098.
40. Pradines, B., A. Spiegel, C. Rogier, A. Tall, J. Mosnier, T. Fusai, J. F. Trape, and D. Parzy. 2000. Antibiotics for prophylaxis of Plasmodium falciparum infections: in vitro activity of doxycycline against Senegalese isolates. Am. J. Trop. Med. Hyg. 62:82-85.
41. Prapunwattana, P., W. J. O'Sullivan, and Y. Yuthavong. 1988. Depression of Plasmodium falciparum dihydroorotate dehydrogenase activity in vitro culture. Mol. Biochem. Parasitol. 27:119-124.
42. Puri, S. K., and N. Singh. 2000. Azithromycin: antimalarial profile against blood- and sporozoite-induced infections in mice and monkeys. Exp. Parasitol. 94:8-14.
43. Rieckmann, K. E., R. D. Powell, J. V. McNamara, D. Willerson, L. Kass, H. Frischer, and P. E. Carson. 1971. Effects of tetracycline against chloraquine-resistant and chloroquine-sensitive Plasmodium falciparum. Am. J. Trop. Med. Hyg. 20:811-815.
44. Robinson, B. L., and D. C. Warhurst. Antimalarial activity of erythromycin. Trans. R. Soc. Trop. Med. Hyg. 66:525.
45. Sande, M. E., and G. L. Marshall. 1980. Antimicrobial agents: tetracyclines and chloramphenicol, p. 1181-1199. In A. G. Goodman, L. S. Goodman, and A. Gilman (ed.), The pharmacological basis of therapeutics, 6th ed. MacMillan Publishing Co., New York, N.Y.
46. Strath, M., T. Scott-Finnigan, M. Gardner, D. Williamson, and I. Wilson. 1993. Antimalarial activity of rifampicin in vitro and in rodent models. Trans. R. Soc. Trop. Med. Hyg. 87:211-216.
47. Tarlow, M. J., S. L. Block, J. Harris, and A. Kolokathis. 1997. Future indications for macrolides. Pediatr. Infect. Dis. J. 16:457-462.
48. Taylor, W. R. G., T. L. Richie, D. J. Fryauff, H. Picarima, C. Ohrt, D. Tang, D. Braitman, G. S. Murphy, H. Widjaja, E. Tjitra, A. Ganjar, T. R. Jones, H. Bastri, and J. Berman. 1999. Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia. Clin. Infect. Dis. 28:74-81.
49. Trape, J. F., G. Pison, M. P. Preziosi, C. Enel, A. Desgrées du Loû, V. Delauney, B. Samb, E. Lagarde, J. F. Molez, and F. Simondon. 1998. Impact of chloroquine resistance on malaria mortality. C. R. Acad. Sci. Paris 321: 689-697.
50. Wall, G., G. D. Shanks, M. D. Einstein, K. Pavanand, and H. K. Webster. 1991. Ciprofloxacin treatment of drug-resistant falciparum malaria. J. Infect. Dis. 164:602-604.
51. Weinberg, E. D. 1999. The role of iron in protozoan and fungal infectious diseases. J. Eukaryot. Microbiol. 46:231-238.
52. Weiss, W. R., A. J. Oloo, A. Johnson, D. Koech, and S. L. Hoffman. 1995. Daily primaquine is effective for prophylasis against falciparum malaria in Kenya: comparison with mefloquine, doxycycline and chloroquine plus proguanil. J. Infect. Dis. 171:1569-1575.
53. Wernsdorfer, W. H. 1991. The development and spread of drug-resistant malaria. Parasitol. Today 7:297-303.
54. Willerson, D., K. E. Rieckmann, P. E. Carson, and H. Frisher. 1972. Effects of minocycline against chloroquine-resistant falciparum malaria. Am. J. Trop. Med. Hyg. 21:857-862.
55. Ye, Z., and K. Van Dyke. 1994. Interaction of artemisinin and tetracycline or erythromycin against Plasmodium falciparum in vitro. Parasite 1:211-218.
56. Yeo, A. E. T., and K. H. Rieckmann. 1994. Prolonged exposure of Plasmodium falciparum to ciprofloxacin increases antimalarial activity. J. Parasitol. 80:158-160.
57. Yeo, A. E. T., and K. H. Rieckmann. 1995. Increased antimalarial activity of azithromycin during prolonged exposure of Plasmodium falciparum in vitro. Int. J. Parasitol. 25:531-532.
58. Yeo, A. E. T., K. H. Rieckmann, and R. I. Christopherson. 1998. Indirect inhibition by antibiotics of nucleotide and deoxynucleotide biosynthesis in Plasmodium falciparum. Southeast Asian J. Trop. Med. Public Health 29: 24-26.